Atenolol Tablets
SOL #: SPE2D2-25-D-0006Award Notice
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Carol Park, AU-QLD, Australia
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Feb 5, 2025
2
Last Updated
Jan 6, 2026
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
SPE2D2-25-D-0006 P00002 to exercise Option Year 1 effective February 05, 2026 through February 04, 2027.
SPE2D2-25-D-0006 P00001 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-25-D-0006 Atenolol Tablets Award
People
Points of Contact
Kyle LewickiPRIMARY
Jason WraySECONDARY
Files
Versions
Version 2Viewing
Award Notice
Posted: Jan 6, 2026
Version 1
Award Notice
Posted: Feb 5, 2025